Funding for this research was provided by:
Canadian Institutes of Health Research (PJT-156306)
Received: 5 November 2020
Accepted: 28 June 2021
First Online: 8 July 2021
: All participants provided both verbal and written informed consent, and ethics approval was obtained from the Hamilton Integrated Research Ethics Board (POST project ID 4556).
: Not applicable.
: Dr. David C. Marsh declares salary income as Chief Medical Director, Canadian Addiction Treatment Centres and as Associate Dean Research, Innovation and International Relations, Northern Ontario School of Medicine. The authors report no other conflict of interest. The authors alone are responsible for the content and writing of this paper.